Cellectis (NASDAQ:CLLS) Given Market Outperform Rating at Citizens Jmp
Citizens Jmp has reiterated a "Market Outperform" rating for Cellectis (NASDAQ:CLLS) with an $8.00 price target, suggesting a significant upside. This rating comes despite the biotechnology company missing EPS estimates but exceeding revenue expectations in its latest quarterly earnings. Institutional investors have notably increased their stakes, with hedge funds and institutions holding a substantial portion of the company's shares.
Cummins Announces Sponsorship of America250 to Support Nation’s 250th Anniversary Commemoration
Cummins Inc., a global power solutions leader, has announced its sponsorship of America250, the national nonpartisan organization leading the commemoration of the 250th anniversary of the signing of the Declaration of Independence. This partnership highlights Cummins' commitment to American progress, innovation, and community engagement, aligning with America250's mission to reflect on the nation's history and inspire future service and collaboration. Both organizations emphasize their shared values of innovation, resilience, and contributing to the next chapter of American development.
Synopsys Solutions Support NASA's Artemis Program with Spacesuit Analysis and Communication System Development
Synopsys is collaborating with NASA's Artemis program by providing solutions for spacesuit analysis and communication system development. They are working with EMA to analyze spacesuit charging levels in the lunar environment and with Cesium and NASA Glenn Research Center to validate lunar cellular network performance using digital twin technology. These efforts aim to reduce risks for extravehicular activities and improve connectivity on the Moon for future missions.
S&P Global Ratings at India's Gujarat International Finance Tec-City (GIFT City)
S&P Global Ratings established a presence in India's Gujarat International Finance Tec-City (GIFT City) in 2025, demonstrating its ongoing commitment to India. The firm actively engages with market participants, providing data-backed insights, contributing to industry forums, and supporting significant transactions to foster the development of India's capital markets. This initiative marks a key milestone in S&P Global Ratings' involvement in the Indian financial sector.
IT Investors Have Opportunity to Lead Gartner, Inc. Securities Fraud Lawsuit with the Schall Law Firm
The Schall Law Firm is encouraging investors of Gartner, Inc. (NYSE: IT) who purchased securities between February 4, 2025, and February 2, 2026, to join a class action lawsuit. The lawsuit alleges that Gartner made false and misleading statements regarding its ability to minimize seasonality, its contract value growth potential, and the improvement in business with "tariff impacted companies," which was not true. Investors who suffered losses are urged to contact the firm before May 18, 2026.
Micron at $420: Buy, Sell or Hold?
Micron Technology (MU) presents a strong bull case at $420.52 due to accelerating AI-driven memory demand and a favorable 7x forward P/E multiple. Despite significant recent gains, the company's position as the sole U.S. DRAM and NAND flash manufacturer, coupled with surging HBM orders, suggests continued growth. Investors are advised to watch Q2 FY2026 results closely to confirm the projected revenue and EPS, which would further strengthen the investment thesis.
7 Best New Ross Dress for Less Spring Decor Finds Flying Off Shelves Right Now
This article highlights the top 7 spring decor finds currently available at Ross Dress for Less, emphasizing their affordability and style. Shoppers can find hidden treasures like trendy outdoor cups, colorful kitchen towels, realistic faux flowers, and LoveShackFancy-inspired throw pillows. The author, Leah Groth, notes that Ross offers great deals on items that are quickly selling out.
Dow appoints insider Karen Carter as CEO
Dow Inc. has announced the appointment of Karen Carter, its current chief operating officer, as the new CEO, effective July 1. She will succeed Jim Fitterling, who will transition to executive chair of the board after leading the company since 2018. This internal promotion signals a focus on leadership continuity for one of the world's largest chemical producers.
Third View Private Wealth LLC Takes Position in Analog Devices, Inc. $ADI
Third View Private Wealth LLC initiated a new position in Analog Devices, Inc. (NASDAQ:ADI) during the fourth quarter, purchasing 28,578 shares valued at approximately $7.75 million. This investment makes Analog Devices the 20th largest holding for Third View Private Wealth, representing 1.0% of its total holdings. While institutional investors collectively own 86.81% of the company, insiders have recently sold shares, including CEO Vincent Roche and CAO Michael Sondel. Analog Devices reported a strong Q4 earnings beat and raised its quarterly dividend, maintaining a "Moderate Buy" consensus rating with an average price target of $370.69.
Third View Private Wealth LLC Takes Position in UnitedHealth Group
Third View Private Wealth LLC has acquired a new stake of 4,336 shares, valued at approximately $1.43 million, in UnitedHealth Group Incorporated during the fourth quarter of 2025. This move signals the investment firm's confidence in the healthcare conglomerate's financial strength and growth potential. UnitedHealth Group is a major healthcare provider in the U.S., and its performance is closely monitored by investors and analysts.



